Dr. Stuart Lee Abramson, MD

Dr. Abramson practices at Shannon Access Clinic - HOPD in San Angelo, Texas.

Dr. Abramson's NPI, 1710984893, was assigned on July 5, 2005. Dr. Abramson graduated from Baylor College Of Medicine in 1984. Dr. Abramson holds Texas license G7962.

Dr. Abramson's primary practice is Shannon Access Clinic - HOPD, at 120 E Beauregard Ave, San Angelo, TX 76903.

Dr. Abramson's primary practice is Shannon Access Clinic - HOPD in San Angelo, Texas. Dr. Abramson is also affiliated with Shannon Medical Center. The medical group on file is Shannon Clinic. Dmand AI also links Dr. Abramson to 2 more group practices and clinics and 1 medical group, each named with a free account. Dr. Abramson's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abramson practices, 4 sites in all. Vendor and product names are available with a free account.

Allergy is Dr. Abramson's primary specialty in the NPI Registry, under taxonomy code 207KA0200X. Dr. Abramson is board certified in allergy & immunology by the American Board of Allergy and Immunology. Dmand AI has Dr. Abramson's licenses on file in 2 states: Texas and Maryland.

Dmand AI lists acid reflux, asthma, chronic nasal allergies, contact dermatitis, hives, itchy rashes and rash among the conditions Dr. Abramson treats.

CMS data shows 1,271 Medicare services from Dr. Abramson across 11 procedure codes in 2024, for 239 Medicare patients. Medicare paid $38,022 for them. Every service was in an office.

CMS counts 239 Medicare patients who saw Dr. Abramson in 2024. The largest group is 65 to 74, with 102 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 10% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abramson's median patient age at 72, with 65% women.

In 2024, Dr. Abramson wrote 1,836 Medicare Part D claims for 309 patients. 65% of them were for generic drugs. CMS names the drug for 1,716 of them, across 27 drugs with 11 or more claims each, at $546,890 in total drug cost. In 2023, CMS named 1,715 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Abramson for performance year 2024, reported as part of a group. Dr. Abramson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abramson as offering telehealth.

Dmand AI links 36 papers to Dr. Abramson, published from 2009 to 2024. 2011 was the busiest year, with 3. The most frequent topics are Asthma, T-Lymphocytes and Self Care. Dr. Abramson has published most often in J Allergy Clin Immunol. Dr. Abramson's most frequent co-authors are Marianna Martin Sockrider, DRPH, MD, Javier Chinen, MD and David Brian Corry, MD.

Dmand AI links Dr. Abramson to 1 clinical trial. Conditions studied include AIDS-Related Complex and Acquired Immunodeficiency Syndrome.

CMS Open Payments shows 183 general payments to Dr. Abramson from 19 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 35% of the total. AstraZeneca Pharmaceuticals LP paid the most, $7,133.

Dmand AI lists 3 awards for Dr. Abramson.

Dr. Abramson graduated from Baylor College Of Medicine in 1984. Dr. Abramson is a member of AAAAI.

Dr. Abramson is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.